To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dual-target superior to standard subacromial corticosteroid injection for shoulder impingement

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2020

Dual-target superior to standard subacromial corticosteroid injection for shoulder impingement

Vol: 9| Issue: 8| Number:11| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

Ultrasound-Guided Standard vs Dual-Target Subacromial Corticosteroid Injections for Shoulder Impingement Syndrome: A Randomized Controlled Trial

Arch Phys Med Rehabil. 2019 Nov;100(11):2119-2128.

Contributing Authors:
JC Wang KV Chang WT Wu DS Han L Ozcakar

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients with shoulder impingement syndrome were randomized to receive a dual-target (long head of bicep tendon and subacromial bursa) subacromial corticosteroid injection or a standard subacromial corticosteroid injection for the relief of pain and improvement of functional outcomes. The primary outcomes of interest were the Shoulder Pain and Disability Index (SPADI) pain, function and tota...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue